Impact of pharmacologic treatment for alcohol use disorder on mortality in patients with alcohol-associated liver disease: analysis from a United States insurance claims database.

The aim of this retrospective cohort study was to evaluate the association of alcohol use disorder (AUD) treatment medications with clinical outcomes in alcohol-associated liver disease (ALD) using a nationwide commercial insurance claims and Medicare supplemental database. We found that patients who received a prescription for a medication to treat AUD after a hospital encounter for ALD had reduced mortality.